Commentary|Videos|July 11, 2025
Advocating for Patients With Psoriasis: Securing Access to Nonsteroidal Topicals Like Roflumilast
Author(s)Mona Shahriari, MD, FAAD, David Hartigan
Fact checked by: Victoria Johnson
In this video, the last in a 6-part series, panelists discuss recent advancements in PsO management.
Advertisement
Advertisement
In this HCPLive RX Review Special Report, Mona Shahriari, MD, Associate Clinical Professor of Dermatology at Yale University, sits down with David Hartigan, a biologic coordinator with Biologic Coordinators of Dermatology, to discuss strategies for overcoming access challenges to non-steroidal topicals like roflumilast foam for people with plaque psoriasis (PsO) on the scalp.
Advertisement
Advertisement
